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oral bacteria in human atheroma derived and
healthy smooth muscle cells
Tanja Pessi1,2,6*, Leena E Viiri2, Emma Raitoharju1, Nagora Astola2, Ilkka Seppälä1, Melanie Waldenberger3,4,
Kari Lounatmaa5, Alun H Davies2, Terho Lehtimäki1, Pekka J Karhunen1 and Claudia Monaco2Abstract
Background: Atherosclerosis is an inflammatory disease with possible contributions from bacterial antigens. We
aimed to investigate the role of oral bacteria as inducers of inflammatory cascades in smooth muscle cells from
carotid endarterectomy patients (AthSMCs) and healthy controls (HSMCs).
Findings: Inactivated Streptococcus mitis, S. sanguinis, S. gorgonii, Aggregatibacter actinomycetemcomitans and
Porphyromonas gingivalis were used to stimulate inflammation in HSMCs and AthSMCs. Tumor necrosis factor-α
(TNFα) was used as a positive control in all stimulations. Interleukin-6 (IL-6) levels were determined from cell culture
supernatants and microRNA expression profiles from cells after 24 h of bacterial stimulation. Genome wide expression
(GWE) analyses were performed after 5 h stimulation. All studied bacteria induced pro inflammatory IL-6 production in
both SMCs. The most powerful inducer of IL-6 was A. actinomycetemcomitans (p < 0.001). Of the 84 studied miRNAs,
expression of 9 miRNAs differed significantly (p≤ 0.001) between HSMCs and AthSMCs stimulated with inactivated
bacteria or TNFα. The data was divided into two groups: high IL-6 producers (A. actinomytectemcomititans and TNFα)
and low IL-6 producers (streptococcal strains and P. gingivalis). The expression of 4 miRNAs (miR-181-5p, −186-5p, −28-5p
and −155-5p) differed statistically significantly (p < 0.001) between healthy HSMCs and AthSMCs in the low IL-6 producer
group. According to multidimensional scaling, two gene expression clusters were seen: one in HSMCs and one AthSMCs.
Conclusions: Our results suggest that inactivated oral bacteria induce inflammation that is differently regulated in
healthy and atherosclerotic SMCs.
Keywords: Atherosclerosis; Inflammation; Genome wide expression; microRNA; Oral bacteria; Smooth muscle cellsIntroduction
Vascular smooth muscle cells (VSMCs) are highly differ-
entiated muscle cells that form the medial layer of the
vessel wall and control blood pressure by contracting
and relaxing the vessels. SMCs play an important role in
atherogenesis, including a key role in remodeling and
plaque stabilization (Doran et al. 2008).
Multiple microRNAs (miRNAs), small non-protein-
coding RNAs, are known to control the different phases
of atherogenesis (reviewed in (Nazari-Jahantigh et al.
2012)). They are responsible for VSMC differentiation* Correspondence: tanja.pessi@uta.fi
1Pirkanmaa Hospital District, University of Tampere School of Medicine and
Fimlab Laboratories Ltd, Tampere, Finland
2Kennedy Institute of Rheumatology, University of Oxford, London, UK
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in any medium, provided the original work is pand proliferation under physiological or pathological
conditions as well as modulating both adaptive and in-
nate immune responses within SMC by encompassing
every step from plaque formation to destabilization and
rupture (Kang and Hata 2012). Although many miRNAs
have been linked to atherosclerosis, only a few miRNAs
(e.g. miR-21, −146a, −150, −155) have repeatedly been
reported (Ma et al. 2013; Raitoharju et al. 2013).
Epidemiological studies have demonstrated a strong
relationship between atherosclerosis and oral infections
(Desvarieux et al. 2005; Desvarieux et al. 2013), possible
due to indirect effects mediated through elevated pro in-
flammatory cytokines and other acute phase proteins.
Several previous studies suggest however that oral bac-
teria can directly penetrate gingival tissues, enter theOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Pessi et al. SpringerPlus  (2015) 4:206 Page 2 of 8bloodstream and potentially induce transient bacteremia
even after flossing, mastication, and tooth brushing (Li
et al. 2000). Of oral pathogens, streptococci and periodon-
tal bacteria are most frequently detected in atherosclerotic
samples (Pessi et al. 2013). It is also known that oral path-
ogens such as Porphyromonas gingivalis and streptococci
have the ability to invade human heart endothelial cells
in vitro (Deshpande et al. 1998; Nagata et al. 2011) as well
as accelerate plaque growth and macrophage invasion
(Kesavalu et al. 2012). In our study, we evaluated the role
of processed periodontal and endodontic bacteria in
atherosclerotic inflammation using SMCs and selected
bacterial species found in coronary plaques after heat in-
activation (Pessi et al. 2013). Atherosclerotic inflammation
was studied by measuring pro inflammatory interleukin-6
(IL-6) levels and gene expression profiles after bacterial
stimulation.
Methods
Bacterial strains
Streptococcus mitis ATCC 49456, Streptococcus sanguinis
ATCC 10556, Streptococcus gorgonii ATCC 10558,
Aggregatibacter actinomycetemcomitans ATCC 700685,
Porphyromonas gingivalis ATCC 33277 from stock
culture collection (LCG Standards AB, Borås, Sweden)
were diluted to 108/ml in sterile phosphate buffered sa-
line (PBS). All bacteria were heat-inactivated and filtered
through a 0.45 μm pore size filter (Merck Millipore,
Darmstadt, Germany) before being added into cell
cultures as previously described (Pessi et al. 1999). These
bacterial preparations were stored at −80°C prior to cell
culture experiments.
Ex vivo culture of cells isolated from human
atherosclerotic plaques and healthy donors
Smooth muscle cells (SMC) were isolated from the carotid
endarterectomies of 4 patients undergoing revasculariza-
tion procedures for symptomatic carotid disease at
Charing Cross Hospital, London. SMCs were isolated and
cultures produced as in Monaco et al. 2004. Aortic SMCs
from 2 healthy donors (HSMCs) were purchased from
PromoCell Ltd (Heidelberg, Germany). The study was
approved by the Research Ethics Committee (Riverside
Research Ethics Committee, London). All patients gave
written informed consent according to the Human Tissue
Act 2004 (UK).
SMCs were grown in SMC growth medium 2 (Promo-
Cell Ltd, Heidelberg, Germany). Viability was monitored
with the use of 3-(4,5-dimethyl-2-yl)-2,5-diphenyltetrazo-
lium (MTT) (Sigma-Aldrich, Carlsbad, California, USA).
After 3–4 passages, SMCs were cultured in Smooth
Muscle Cell Growth Medium 2 (PromoCell) either alone
or in the presence of each of the bacterial preparations
separately at a final concentration of 107, 106 and 105/mlof culture media. Tumor necrosis factor alpha (TNF-α)
(InvivoGen, Source BioScience LifeSciences, Nottingham,
UK) was used as a positive control at a concentration of
10 ng/ml. After culturing SMCs with or without bacterial
stimulation for 24 h, cell culture supernatants were
collected for IL-6 measurement, and cell pellets for
miRNA expression profiling. Separate experiments were
performed for GWE analyses using the same bacterial
preparations. Pellets for GWE analyses were collected
after 5 h of stimulation.
Interleukin-6 measurements
Cell culture supernatants were removed after 24 hours
and stored at −80°C for single-batch cytokine analysis
using the DuoSet ELISA Development Systems (R&D
Systems, Minneapolis, USA), according to the manufac-
turer’s instructions. The ELISA detection limit was 2 pg/ml.
Experiments were performed in triplicate.
RNA isolation and expression profiling
Total RNA for miRNA and GWE was isolated using the
miRNeasy Mini Kit (Qiagen Ltd, Valencia, USA), and
miRNA profiling of 84 commonly known miRNAs was
performed using miScript miRNA Array (MIHS-001Z,
Qiagen) according to the manufacturer’s instructions.
Due to its lowest standard deviation between runs,
SNORD68 was selected as a housekeeping gene. Samples
with a Ct value ≥35 were excluded from analyses. Of
2016 measurements, 17 failures were observed and
excluded from further analyses.
Whole genome gene expression (GWE) analysis was
performed with Illumina DirectHyb HumanHT-12 v4.0
(Illumina, Inc., San Diego, USA) containing 47,231 oligo-
nucleotide probes representing 34,602 genes, and proc-
essed according to the manufacturer’s protocol. The
normalization was applied by subtracting the signal
intensity of each probe in each sample by the mean
intensity for that sample across all probes (global mean
normalization). After normalization, multidimensional
scaling (MDS) was used to illustrate global gene expres-
sions of each sample in two-dimensional spaces (Cox
and Cox 2001).
Transmission electron microscopy
To visualize the bacterial processing in SMCs, AthSMCs
were selected after 24 h stimulation with S. mitis for
electron microscopy (EM, Figure 1) with a JEOL 1200EX
transmission electron microscope (Japanese Electron
Optics Laboratory, Tokyo, Japan) operating at 60 kV.
Statistical analyses
All results (IL-6 levels, miRNA and GWE) were normal-
ized against the corresponding results obtained from
cultures without the addition of inactivated bacteria.
Figure 1 Phagocytosis of S. mitis by AthSMCs. Arrows indicate bacteria and their components. Bar is 0.5 μm.
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statistical differences between the experiments were calcu-
lated using the non-parametric Mann Whitney U test and
Spearman’s correlation test. Of IL-6 results p < 0.01 was
considered to be statistically significant, and due to the
multiple measurements of the miRNA results p ≤ 0.001
was considered statistically significant (PASW Statistical
Software version 18; SPSS Ltd, Quarry Bay, Hong Kong,
China).S. mitis S.sanqui S.gordonii
Figure 2 The production of IL-6 induced by inactivated oral bacteria at the
(HSMCs, n = 2) and atheroma derived SMCs (AthSMCs, n = 4). Means (+SD)
(no stimulus). Statistically significant differences (*; p = 0.01 and **; p = 0.001) ar
gingivalis; A. act, Aggregatibacter actinomycetemcomitans; TNF-α, tumor necrosisResults
IL-6 production induced by oral bacteria
All studied bacteria (S. mitis, S. sangui, S. gordonii, P.
gingivalis, A. actinomycetemcomitans) and TNFα induced
IL-6 production in AthSMCs as well as in healthy SMCs
(Figure 2). Among bacterial stimulations, the most power-
ful inducer was A. actinomycetemcomitans (p < 0.001,
Mann Whitney U test). IL-6 responses induced by other
bacteria did not differ from each other (p>0.01). TheP.ging A.act
concentration of 107/ml and TNF-α (10 ng/ml) in healthy SMCs
are expressed as induction folds compared to medium values
e marked in the figure. S. Streptococcus; P. ging, Porphyromonas
factor-α. Red bar represents from AthSMCs results and blue from HSMCs.
Table 1 Fold changes of stimulated miRNAs in healthy and atherosclerotic SMCs
HSMCs AthSMCs
Percentiles Percentiles
miRNA ID Accession number Median 25th 75th Median 25th 75th p-value*
hsa-miR-142-5p MIMAT0000433 −1.58 −1.98 0.67 −0.05 −1.89 2.08
hsa-miR-9-5p MIMAT0000441 −2.31 −4.05 −1.49 −1.51 −2.33 1.71 0.045
hsa-miR-150-5p MIMAT0000451 −2.01 −2.69 −1.03 3.18 −0.4 4.31 0.002
hsa-miR-27b-3p MIMAT0000419 −1.25 −1.53 1.05 −1.42 −1.74 0.68
hsa-miR-101-3p MIMAT0000099 3.39 1.61 5.33 1.05 −1.47 2.05 0.007
hsa-let-7d-5p MIMAT0000065 −1.26 −1.47 −1.05 1.05 −1.07 1.1 0.014
hsa-miR-103a-3p MIMAT0000101 −0.02 −1.32 1.44 −1.07 −1.28 1.1
hsa-miR-16-5p MIMAT0000069 −1.32 −1.76 0.48 −0.02 −1.17 1.19
hsa-miR-26a-5p MIMAT0000082 −1.18 −1.4 1.2 −1.78 −2.04 −1.15
hsa-miR-32-5p MIMAT0000090 1.22 −1.12 3.4 4.01 1.56 5.69
hsa-miR-26b-5p MIMAT0000083 −1.37 −1.87 −1.08 −1.77 −2.19 −1.32
hsa-let-7 g-5p MIMAT0000414 −1.41 −1.88 −1.18 −1.23 −1.56 0.53
hsa-miR-30c-5p MIMAT0000244 −1.19 −1.52 1.09 −1.71 −2.25 −1.11
hsa-miR-96-5p MIMAT0000095 −3.54 −4.93 −1.53 1.43 1.13 3.41 <0.001
hsa-miR-185-5p MIMAT0000455 2.07 1.43 3.15 −1.25 −1.3 −1.02 <0.001
hsa-miR-142-3p MIMAT0000434 −1.11 −1.54 2.65 2.18 1.9 3.98 0.014
hsa-miR-24-3p MIMAT0000080 1.03 −1.13 1.25 −1.12 −1.48 1.22
hsa-miR-155-5p MIMAT0000646 −1.4 −1.63 −1.18 1.06 −1.12 1.31 0.003**
hsa-miR-146a-5p MIMAT0000449 −1.61 −2.01 −1.17 −2.01 −2.48 −1.32
hsa-miR-425-5p MIMAT0003393 1.24 −0.5 1.49 −1.16 −1.65 0.61
hsa-miR-181b-5p MIMAT0000257 −1.27 −1.39 −1.14 1.13 −0.55 1.34 <0.001**
hsa-miR-302b-3p MIMAT0000715 −1.97 −3.13 0.46 −1.84 −2.83 −1.15
hsa-miR-30b-5p MIMAT0000420 −1.09 −1.3 1.13 −1.25 −1.54 0.6
hsa-miR-21-5p MIMAT0000076 −1.69 −2.72 −1.37 −1.98 −2.36 −1.23
hsa-miR-30e-5p MIMAT0000692 1.46 1.09 2.09 −1.15 −1.45 1.18 0.008
hsa-miR-200c-3p MIMAT0000617 −1.79 −2.51 −1.5 1.47 1.04 2.38 <0.001
hsa-miR-15b-5p MIMAT0000417 −1.06 −1.29 1.12 −0.09 −1.47 1.24
hsa-miR-223-3p MIMAT0000280 −2.6 −5.45 −1.14 −1.48 −1.8 7.44
hsa-miR-194-5p MIMAT0000460 1.06 −1.24 1.47 −1.65 −2.01 0.59
hsa-miR-210-3p MIMAT0000267 2.65 1.39 4.49 2.02 1.52 2.34
hsa-miR-15a-5p MIMAT0000068 2.07 1.61 2.95 1.14 −1.4 1.8 0.024
hsa-miR-181a-5p MIMAT0000068 1.78 1.33 2.72 1.34 −1.29 1.58 0.028
hsa-miR-125b-5p MIMAT0000423 1.1 −1.11 1.5 −1.51 −2.11 −1.16 0.01
hsa-miR-99a-5p MIMAT0000097 1.07 −1.12 1.41 −1.74 −2.04 0.55
hsa-miR-28-5p MIMAT0000085 1.82 1.3 2.13 −1.43 −1.78 1.05 <0.001**
hsa-miR-320a MIMAT0000510 −0.02 −1.46 1.22 1.13 −1.05 1.38
hsa-miR-125a-5p MIMAT0000443 −1.48 −3.1 0.55 −1.21 −1.89 1.42
hsa-miR-29b-3p MIMAT0000100 2.02 1.39 4.66 2 −1.1 2.65
hsa-miR-29a-3p MIMAT0000086 1.43 −0.57 1.86 −1.03 −1.18 1.57
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Table 1 Fold changes of stimulated miRNAs in healthy and atherosclerotic SMCs (Continued)
hsa-miR-141-3p MIMAT0000432 −0.09 −1.98 2.1 2.08 −0.49 3.03
hsa-miR-19a-3p MIMAT0000073 1.82 −0.51 3.2 −1.06 −1.37 1.69
hsa-miR-18a-5p MIMAT0000072 0.05 −1.19 1.6 −0.04 −1.28 1.13
hsa-miR-374a-5p MIMAT0000727 −1.28 −1.56 0.5 −1.53 −2.1 −1.03
hsa-miR-423-5p MIMAT0004748 −1.2 −1.34 0.5 1.2 1.02 1.52 0.002
hsa-let-7a-5p MIMAT0000062 −1.53 −1.9 −1.26 −1.02 −1.13 1.13 0.001
hsa-miR-124-3p MIMAT0000422 1.15 −1.86 3.06 1.93 1.13 3.97
hsa-miR-92a-3p MIMAT0000092 −0.03 −1.37 1.22 −1.06 −1.13 1.18
hsa-miR-23a-3p MIMAT0000078 −1.34 −1.98 −1.04 −1.5 −1.7 −1.13
hsa-miR-25-3p MIMAT0000081 −1.47 −2.14 −1.27 −1.73 −1.97 −1.08
hsa-let-7e-5p MIMAT0000066 −1.55 −1.87 −1.26 1.16 −1.04 1.32 <0.001
hsa-miR-376c-3p MIMAT0000720 2.08 1.34 2.73 −1.43 −1.63 1.5 0.006
hsa-miR-126-3p MIMAT0000445 1.2 −1.08 1.98 −0.09 −1.52 1.44
hsa-miR-144-3p MIMAT0000436 −2.07 −3.78 1.88 1.21 −1.49 3.64
hsa-miR-424-5p MIMAT0001341 −1.46 −2.18 −1.09 −1.63 −1.78 0.44
hsa-miR-30a-5p MIMAT0000087 1.6 1.1 2.06 −0.03 −1.24 1.35
hsa-miR-23b-3p MIMAT0000418 −1.5 −1.99 0.48 −1.24 −1.61 0.5
hsa-miR-151a-5p MIMAT0004697 −0.01 −1.21 1.35 −1.59 −2.01 −1.13 0.02
hsa-miR-195-5p MIMAT0000461 −1.07 −1.27 0.53 1.22 1.13 1.45 0.005
hsa-miR-143-3p MIMAT0000435 2.26 1.85 4.34 1.28 −0.5 2.15
hsa-miR-30d-5p MIMAT0000245 0.02 −1.48 1.42 −1.14 −1.38 1.15
hsa-miR-191-5p MIMAT0000440 −1.1 −1.24 1.23 −1.47 −1.73 0.53
hsa-let-7i-5p MIMAT0000415 1.15 1.08 1.41 1.1 −1.16 1.32
hsa-miR-302a-3p MIMAT0000684 −1.06 −1.19 1.4 −1.25 −1.85 1.13
hsa-miR-222-3p MIMAT0000279 1.4 −0.53 1.85 −1.52 −1.65 0.55 <0.001
hsa-let-7b-5p MIMAT0000063 1.14 −1.09 1.42 1.96 1.53 2.14 0.002
hsa-miR-19b-3p MIMAT0000074 1.64 −1.4 3.14 0.07 −1.15 1.67
hsa-miR-17-5p MIMAT0000070 1.63 1.26 2.28 −1.02 −1.32 1.3 0.002
hsa-miR-93-5p MIMAT0000093 1.23 −1.18 2.45 0.01 −1.45 1.35
hsa-miR-186-5p MIMAT0000456 −1.94 −2.44 −1.37 1.34 −0.54 1.64 <0.001**
hsa-miR-196b-5p MIMAT0001080 1.46 −3.14 7.09 1.81 −1.24 6.42
hsa-miR-27a-3p MIMAT0000084 1.33 −0.54 1.65 −1.04 −1.34 1.36
hsa-miR-22-3p MIMAT0000077 2.42 1.44 4.24 1.35 −0.6 2.19 0.003
hsa-miR-130a-3p MIMAT0000425 1.6 1.15 2.06 2.05 −0.6 3.12
hsa-let-7c MI0000064 −1.2 −1.35 1.17 0.01 −1.08 1.57
hsa-miR-29c-3p MIMAT0000681 1.41 −0.53 1.84 1.04 −1.34 1.25
hsa-miR-140-3p MIMAT0004597 1.69 −0.57 3.06 −1.24 −1.62 1.1 0.008
hsa-miR-128-3p MIMAT0000424 −1.18 −1.48 0.58 −1.44 −1.73 0.48
hsa-let-7f-5p MIMAT0000067 −1.6 −1.91 −1.39 −1.4 −2.02 −1.14
hsa-miR-122-5p MIMAT0000421 −1.84 −4.05 −1.01 1.65 −0.59 3.24 0.028
hsa-miR-20a-5p MIMAT0000075 1.36 −0.53 2 −1.38 −1.56 0.53 0.004
hsa-miR-106b-5p MIMAT0000680 2.06 −0.41 2.69 −0.03 −1.27 1.23 0.006
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Table 1 Fold changes of stimulated miRNAs in healthy and atherosclerotic SMCs (Continued)
hsa-miR-7-5p MIMAT0000252 −1.53 −2.98 −1.37 −1.45 −2.61 0.49
hsa-miR-100-5p MIMAT0000098 −1.05 −1.36 1.19 −1.85 −2.09 1.05
hsa-miR-302c-3p MIMAT0000717 −1.17 −1.74 3.62 1.9 1.2 2.27
*Mann–Whitney U test.
**When data was divided into low and high IL-6 stimulants, highly significant results (P < 0.001) were observed in the group of low IL-6 stimulants, like streptococci and
P. gingivalis (see Figures 2 and 3).
Fold changes calculated using unstimulated cells as a reference. The data from different stimuli (streptococci, P. gingivalis, A. actinomytectemcomititans or TNFα)
were pooled and median values presented with 25th and 75th interquartile ranges. P-values < 0.05 are presented. P-values < 0.001 in bold.
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in both cell types (data not shown).
miRNA and GWE profiles in SMCs after stimulation
miRNA expression profiles in AthSMCs and HSMCs were
studied after 24 h bacterial stimulation. Of the 84
miRNAs, 9 (miR-96-5p, −185-5p, −181b-5p, −200c-3p,
−28-5p, −222-3p, −186-5p, let7a-5p and let7e-5p) were
statistically significantly differently expressed (Table 1 and
Additional file 1: Table S1) in AthSMC and HSMCs after
bacterial stimulation (p < 0.001). Since IL-6 levels produced
by SMCs after stimulation with A. actinomytectemcomiti-
tans significantly differed to IL-6 levels after stimulation
with other bacteria, the data was divided into two groups:
“high IL-6 producers” i.e. A. actinomytectemcomititans and
TNF-α and “low IL-6 producers”, i.e. different streptococci
and P. gingivalis. It was observed that in the “low IL-6 pro-
ducer” group (Figure 3), the expression of 4 miRNAs
(miR-181b-5p, −186-5p, −28-5p and −155-5p) differed
statistically significantly between HSMCs and AthSMCsFigure 3 Fold changes of miRNAs (A; miR-181b-5p, B;186-5p, C; 28-5p, D;1
stimulation in healthy SMCs (HSMCs) and atheroma derived SMCs (AthSMC
without bacteria. Each stimulation was performed twice, red circles represe(p <0.001; Mann- Whitney U test). The expression of 3
miRNAs (miR-155-5p, −150-5p and −9-5p) correlated with
IL-6 levels (p < 0.001, Spearman’s correlation).
Multidimensional scaling (MDS) from GWE data was
performed for illustrative purposes to evaluate global
expression of stimulated genes in SMCs (Figure 4). Global
gene expression profiles were similar for samples stimu-
lated with oral bacteria within the same SMC type with
the exception of by A. actinomycetemcomitans in HSMCs.
Two expression profile cluster were observed according to
cell type: HSMC and AthSMC. This difference was clearly
seen in dimension 1 vs. 2 (Figure 4) as well as in dimen-
sion 1 vs. 3 (data not shown).
Discussion and conclusion
The present results confirm that the studied attenuated
oral bacteria have the ability to activate a pro-inflammatory
response in vascular smooth muscle cells. A. actinomyce-
temcomitans was the most potent inducer of inflammation
and differed from other bacteria in its capacity to induce55-5p, E;150-5p, F; 9-5p) and IL-6 levels after streptococci or P. gingivalis
s). N-fold difference compared to corresponding values from cultures
nt AthSMCs results and blue circles from HSMCs.
Figure 4 Dimensions 1 and 2 from the multidimensional scaling (MDS) of GWE data in healthy SMCs (HSMCs) and atheroma derived SMCs
(AthSMCs) stimulated with oral bacteria and tumor necrosis factor (TNF)-α, S., Streptococcus; P., Porphyromonas; A., Aggregatibacter. Red circles
represent AthSMCs results and blue from HSMCs.
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expression profiles.
After bacterial stimulation miRNA profiles were differ-
ent in atherosclerotic SMCs and in healthy SMCs, which
has not been studied before. The down regulation of miR-
185-5p after bacterial stimulation in AthSMCs was in line
with studies on carotid plaques without bacterial stimula-
tion (Raitoharju et al. 2011; Raitoharju et al. 2013) sug-
gesting that bacterial stimulation per se does not change
the direction of miRNA expression. Expression levels
(with or without bacterial stimulation) of other 8 miRNAs
(miR-96-5p, −181b-5p, −185-5p, −200c-3p, −222-3p, −28-
5p, let-7a-5p) in atherosclerotic tissues have not been
identified before (see supplement summary), however
their characterized functions (explained in the Additional
file 1: Table S1) support their involvement in atheroscler-
otic inflammation.
miRNA results from ‘the low-IL-6 producers’, i.e. stimu-
lation with streptococci and P. gingivalis were separately
evaluated. Our result show down-regulation of miR 28-5p,
which may result in the enhancement of several inflam-
matory markers and adhesion molecules, as suggested by
Stather et al. (2013). We also detected upregulated miR-
181b-5p and −186-5p, which may suppress plasminogen
activator inhibitor-1 in VSMCs (Chen et al. 2014) and
promote apoptosis (Zhou et al. 2008), thus interfering
with extracellular matrix degradation, and structural and
functional changes in VSMCs. miR-155 is highly
expressed in various cell types including VSMCs and
endothelial cells (Faraoni et al. 2009). It changes endothe-
lial cell morphology and modulates the endothelial pheno-
type via re-organizing the actin cytoskeleton (Weber et al.
2014). Upregulated miR-155 also attenuates endothelial
cell migration, proliferation, and apoptosis in atheroscler-
otic plaques (Weber et al. 2014). miR-155-5p was highly
expressed in AthSMCs after bacterial stimulation and itsexpression also correlated with IL-6 levels, suggesting a
potential role for this miRNA in bacterial-induced athero-
sclerotic inflammation.
Multidimensional scaling (MDS) summarizes genome
wide expression (GWE) data of each sample and displays
a structure of distance-like data as a geometrical picture
illustrating similarities or dissimilarities between each
sample (Cox and Cox 2001). Dots in the picture of di-
mensions 1 vs. 2 demonstrate major variances occurring
in global gene expressions. Dots in MDS figures do not,
however, explain which and how many genes are differ-
ently expressed. Two major clusters were seen here, i.e.
one among HSMCs and one among AthSMCs. This is in
line with our findings observed in the miRNA profiles.
Although our study is a pilot study with limited num-
bers, it is a novel study looking at the effects of attenuated
oral bacteria in inducing inflammation in both healthy
and atherosclerotic SMCs. No previous studies have com-
bined both traditional inflammatory markers, like IL-6, as
well as newly discovered gene expression markers in
bacterial-induced atherosclerosis. The relatively low ex-
pression levels induced by attenuated bacteria may indi-
cate that certain bacterial antigens from attenuated
bacterial cells could have some role in smouldering
atherosclerotic inflammation.
Additional file
Additional file 1: Table S1. Function of 9 miRNAs differently expressed
in AthSMC and HSMCs after streptococci and P. gingivalis stimulation.
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